What's in a name?

Hepatology

Volumn 50, Issue 3, 2009, Pages 663-667

  Brunt, Elizabeth M ^a  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BODY MASS; DISEASE ASSOCIATION; DISEASE COURSE; EDITORIAL; HISTOPATHOLOGY; HUMAN; INFLAMMATION; LIPID STORAGE; LIVER BIOPSY; LIVER CIRRHOSIS; LIVER FATTY DEGENERATION; NOMENCLATURE; NONALCOHOLIC FATTY LIVER; OBESITY; PRIORITY JOURNAL; ADULT; CHILD; CLASSIFICATION; FATTY LIVER; LIVER; PATHOLOGY;

ADULT; CHILD; FATTY LIVER; HUMANS; LIVER; OBESITY; TERMINOLOGY AS TOPIC;

EID: 70349246512     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1002/hep.23070     Document Type: Editorial

References (50)

1. Farrell GC. Drugs and steatohepatitis. Semin Liver Dis 2002;22:185-194.
2. Dixon JB, O'Brien PE, Bhatal PS. A wider view on diagnostic criteria of nonalcoholic steatohepatitis (reply). Gastroenterology 2002;122:841-842.
3. Neuschwander-Tetri BA, Caldwell SH. Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. HEPATOLOGY 2003;37:1202-1219.
4. Loria P, Lonardo A, Carulli N. Should nonalcoholic fatty liver disease be renamed? Dig Dis 2005;23:72-82.
5. Uchida T, Kao H, Quispe-Sjogren M, Peters RL. Alcoholic foamy degeneration - a pattern of acute alcoholic injury of the liver. Gastroenterology 1983;84:683-692. (Pubitemid 13152612)
6. Burt AD, MacSween RNM. Hepatic vein lesions in alcoholic liver disease: retrospective biopsy and necropsy study. J Clin Pathol 1986;39:63-67.
7. Goodman ZD, Ishak KG. Occlusive venous lesions in alcoholic liver disease. Gastroenterology 1982;83:786-796.
8. Hall PDLM. Alcoholic liver disease. In: Burt AD, Portmann BG, Ferrell L, eds. MacSween's Pathology of the Liver. 5th ed. Edinburgh, United Kingdom: Churchill Livingstone; 2007:327-366.
9. Yip WW, Burt AD. Alcoholic liver disease. Semin Diagn Pathol 2007;23:149-160.
10. Lefkowitch JH. Morphology of alcoholic liver disease. Clin Liver Dis 2005;9:37-53.
11. García-Monzón C, Martín-Pérez E, Iacono OL, Fernández-Bermejo M, Majano PL, Apolinario A, et al. Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 2000;33:716-724. (Pubitemid 30823703)
12. Dixon JB, Bhatal PS, O'Brien PE. Nonalcoholic fatty liver disease: predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese. Gastroenterology 2001;121:91-100. (Pubitemid 32591518)
13. Younossi ZM, Gramlich T, Liu YC, Matteoni C, Petrelli M, Goldblum J, et al. Nonalcoholic fatty liver disease - assessment of variability in pathologic interpretations. Mod Pathol 1998;11:560-565. (Pubitemid 28280720)
14. Lee RG. Nonalcoholic steatohepatitis: tightening the morphological screws on a hepatic rambler. HEPATOLOGY 1995;21:1742-1743.
15. Browning JD, Szczepaniak LS, Dobbins R, Nuremberg P, Horton JD, Cohen JC, et al. Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity. HEPATOLOGY 2004;40:1387-1395. (Pubitemid 39657013)
16. Mofrad P, Contos MJ, Haque M, Sargeant C, Fisher RA, Luketic VA, et al. Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT values. HEPATOLOGY 2003;37:1286-1292. (Pubitemid 36667307)
17. Fracanzani AL, Valenti L, Bugianesi E, Andreoletti M, Colli A, Vanni E, et al. Risk of severe liver disease in nonalcoholic fatty liver disease with normal aminotransferase levels: a role for insulin resistance and diabetes. HEPATOLOGY 2008;48:792-798.
18. A-Kader HH, Henderson J, Vanhoesen K, Ghishan F, Bhattacharya A. Nonalcoholic fatty liver disease in children: a single center experience. Clin Gastroenterol Hepatol 2008;6:799-802.
19. Adinolfi LE, Gambardella M, Andreana A, Tripodi MF, Utili R, Ruggiero G. Steatosis accelerates the progression of liver damage of chronic hepatitis C patients and correlates with specific HCV genotype and visceral obesity. HEPATOLOGY 2001;33:1358-1364. (Pubitemid 32496971)
20. Hickman IJ, Clouston AD, Macdonald GA, Purdie DM, Prins JB, Ash S, et al. Effect of weight reduction on liver histology and biochemistry in patients with chronic hepatitis C. Gut 2002;51:89-94. (Pubitemid 34717750)
21. Clouston AD, Powell EE. Interaction of non-alcoholic fatty liver disease with other liver diseases. Best Pract Res Clin Gastroenterol 2002;16:767-781. (Pubitemid 38001861)
22. Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. HEPATOLOGY 2005;42:5-13.
23. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116:1413-1419. (Pubitemid 29258890)
24. Deivanayagam S, Mohammed BS, Vitola BE, Naguib GH, Keshen TH, Kirk EP, et al. Nonalcoholic fatty liver disease is associated with hepatic and skeletal muscle insulin resistance in overweight adolescents. Am J Clin Nutr 2008;88:257-262.
25. Fabbrini E, deHaseth D, Deivanayagam S, Mohammed BS, Vitola BE, Klein S. Alterations in fatty acid kinetics in obese adolescents with increased intrahepatic triglyceride content. Obesity (Silver Spring) 2009;17:25-29.
26. Fabbrini E, Mohammed BS, Magkos F, Korenblat KM, Patterson BW, Klein S. Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease. Gastroenterology 2008;134:424-431. (Pubitemid 351173050)
27. Korenblat KM, Fabbrini E, Mohammed BS, Klein S. Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects. Gastroenterology 2008;134:1369-1375. (Pubitemid 351615354)
28. Rubinstein R, Lavine JE, Schwimmer JB. Hepatic, cardiovascular, and endocrine outcomes of the histologic subphenotypes of nonalcoholic fatty liver disease. Semin Liver Dis 2008;28:380-385.
29. Misra VL, Khashab M, Chalasani N. Nonalcoholic fatty liver disease and cardiovascular risk. Curr Gastroenterol Rep 2009;11:50-55.
30. Targher G, Bertolini L, Padovani R, Rodella S, Tessari R, Zenari L, et al. Prevalence of nonalcoholic fatty liver disease and its association with cardiovascular disease among type 2 diabetic patients. Diabetes Care 2007;30:1212-1218. (Pubitemid 46684650)
31. Bell M, Wang H, Chen H, McLenithan JC, Gong DW. Consequences of lipid droplet coat protein downregulation in liver cells: abnormal lipid droplet metabolism and induction of insulin resistance. Diabetes 2008;57:2037-2045.
32. de Ferranti S, Mozaffarian D. The perfect storm: obesity, adipocyte dysfunction, and metabolic consequences. Clin Chem 2008;54:945-955. (Pubitemid 351793400)
33. Weston SR, Leyden W, Murphy R, Bass NM, Bell BP, Manos MM, et al. Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease. HEPATOLOGY 2005;41:372-379. (Pubitemid 40165382)
34. Guerrero R, Vega GL, Grundy SM, Browning JD. Ethnic differences in hepatic steatosis: an insulin resistance paradox? HEPATOLOGY 2009;49:791-801.
35. Chitturi S, Farrell GC, George J. Nonalcoholic steatohepatitis in the Asia-Pacific region: future shock? J Gastroenterol Hepatol 2004;19:368-374.
36. Farrell GC, Chitturi S, Lau GKK, Sollano JD, and the Asia-Pacific Working Party on NAFLD. Guidelines for the assessment and management of nonalcoholic fatty liver disease in the Asia-Pacific region: executive summary. J Gastroenterol Hepatol 2007;22:775-777.
37. Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, et al. Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. HEPATOLOGY 2007;45:1366-1374. (Pubitemid 46918320)
38. Puri P, Baillie RA, Wiest MM, Mirshahi F, Choudhury J, Cheung O, et al. A lipidomic analysis of nonalcoholic fatty liver disease.HEPATOLOGY 2007;46:1081-1090.
39. Brunt EM, Kleiner DE, Wilson LA, Unalp A, Behling CE, Lavine JE, et al. Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-clinicopathologic correlations from the nonalcoholic steatohepatitis clinical research network. HEPATOLOGY 2009;49:809-820.
40. Schwimmer JB, Behling C, Newbury R, Deutsch R, Nievergelt C, Schork NJ, et al. Histopathology of pediatric nonalcoholic fatty liver disease. HEPATOLOGY 2005;42:641-649. (Pubitemid 41233657)
41. Kleiner DE, Behling C, Brunt EM, Lavine JE, McCullough AJ, Sanyal AJ, et al. Comparison of adult and pediatric NAFLD - confirmation of a second pattern of progressive fatty liver disease in children [Abstract]. HEPATOLOGY 2006;44(Suppl 1):259A.
42. Nobili V, Marcellini M, Devito R, Ciampalini P, Piemonte F, Comparcola D, et al. NAFLD in children: a prospective clinical-pathological study and effect of lifestyle advice. HEPATOLOGY 2006;44:458-465. (Pubitemid 44214885)
43. Carter-Kent CA, Yerian LM, Brunt EM, Angulo P, Kohli R, et al. Nonalcoholic steatohepatitis in children: a multicenter clinicopathological study [Abstract]. HEPATOLOGY 2008;48(Suppl):804A.
44. Patton HM, Lavine JE, Van Natta ML, Schwimmer JB, Kleiner D, Molleston J. Clinical correlates of histopathology in pediatric nonalcoholic steatohepatitis. Gastroenterology 2008;135:1961-1971.
45. Tetri LH, Basaranoglu M, Brunt EM, Yerian LM, Neuschwander-Tetri BA. Severe NAFLD with hepatic necroinflammatory changes in mice fed trans fats and a high-fructose corn syrup equivalent. Am J Physiol Gastrointest Liver Physiol 2008;295:G987-G995.
46. Neuschwander-Tetri BA, Tetri LH, Brunt EM. NASH and extensive pericellular fibrosis in ALIOS mice fed industrial trans-fats for one year [Abstract]. HEPATOLOGY 2008;48(Suppl):836A.
47. Clouston AD, Powell EE, Walsh MJ, Richardson MM, Demetris AJ, Jonsson JR. Fibrosis correlates with a ductular reaction in hepatitis C: roles of impaired replication, progenitor cells and steatosis. HEPATOLOGY 2005;41:809-819.
48. Richardson MM, Jonsson JR, Powell EE, Brunt EM, Neuschwander-Tetri BA, Bhathal PS, et al. Progressive fibrosis in non-alcoholic steatohepatitis - altered regeneration and the ductular reaction. Gastroenterology 2007;133:80-90.
49. Rygiel KA, Robertson H, Marshall HL, Pekalski M, Zhao L, Booth TA, et al. Epithelial-mesenchymal transition contributes to portal tract fibrogenesis during human chronic liver disease. Lab Invest 2008;88:112-123. (Pubitemid 351161272)
50. Omenetti A, Porrello A, Jung Y, Yang L, Popov Y, Choi SS, et al. Hedgehog signaling regulates epithelial-mesenchymal transition during biliary fibrosis in rodents and humans. J Clin Invest 2008;118:3331-3342.